BIIB logo

Biogen (BIIB) Cash from operations

annual CFO:

$2.88B+$1.33B(+85.85%)
December 31, 2024

Summary

  • As of today (June 7, 2025), BIIB annual cash flow from operations is $2.88 billion, with the most recent change of +$1.33 billion (+85.85%) on December 31, 2024.
  • During the last 3 years, BIIB annual CFO has fallen by -$764.40 million (-21.00%).
  • BIIB annual CFO is now -59.38% below its all-time high of $7.08 billion, reached on December 31, 2019.

Performance

BIIB Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

quarterly CFO:

$259.30M-$501.60M(-65.92%)
March 31, 2025

Summary

  • As of today (June 7, 2025), BIIB quarterly cash flow from operations is $259.30 million, with the most recent change of -$501.60 million (-65.92%) on March 31, 2025.
  • Over the past year, BIIB quarterly CFO has dropped by -$293.90 million (-53.13%).
  • BIIB quarterly CFO is now -86.80% below its all-time high of $1.96 billion, reached on June 30, 2019.

Performance

BIIB quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

TTM CFO:

$2.58B-$293.90M(-10.22%)
March 31, 2025

Summary

  • As of today (June 7, 2025), BIIB TTM cash flow from operations is $2.58 billion, with the most recent change of -$293.90 million (-10.22%) on March 31, 2025.
  • Over the past year, BIIB TTM CFO has increased by +$936.50 million (+56.93%).
  • BIIB TTM CFO is now -63.57% below its all-time high of $7.09 billion, reached on March 31, 2020.

Performance

BIIB TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BIIB Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+85.8%-53.1%+56.9%
3 y3 years-21.0%+60.3%-14.9%
5 y5 years-59.4%-82.3%-63.6%

BIIB Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-21.0%+107.7%-72.3%+248.2%-14.9%+89.9%
5 y5-year-59.4%+107.7%-86.7%+170.6%-63.6%+89.9%
alltimeall time-59.4%>+9999.0%-86.8%+170.6%-63.6%>+9999.0%

BIIB Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$259.30M(-65.9%)
$2.58B(-10.2%)
Dec 2024
$2.88B(+85.9%)
$760.90M(-18.7%)
$2.88B(+35.2%)
Sep 2024
-
$935.60M(+49.5%)
$2.13B(+19.2%)
Jun 2024
-
$625.80M(+13.1%)
$1.78B(+8.4%)
Mar 2024
-
$553.20M(+4325.6%)
$1.65B(+6.3%)
Dec 2023
$1.55B(+11.8%)
$12.50M(-97.9%)
$1.55B(+13.8%)
Sep 2023
-
$592.40M(+21.6%)
$1.36B(-4.8%)
Jun 2023
-
$487.00M(+7.0%)
$1.43B(-14.9%)
Mar 2023
-
$455.30M(-360.2%)
$1.68B(+21.2%)
Dec 2022
$1.38B(-62.0%)
-$175.00M(-126.5%)
$1.38B(-42.3%)
Sep 2022
-
$661.00M(-10.3%)
$2.40B(-5.7%)
Jun 2022
-
$736.50M(+355.2%)
$2.54B(-16.2%)
Mar 2022
-
$161.80M(-80.7%)
$3.03B(-16.7%)
Dec 2021
$3.64B(-13.9%)
$838.30M(+4.1%)
$3.64B(+49.5%)
Sep 2021
-
$805.30M(-34.4%)
$2.43B(-13.4%)
Jun 2021
-
$1.23B(+59.6%)
$2.81B(-20.4%)
Mar 2021
-
$769.00M(-309.5%)
$3.53B(-16.5%)
Dec 2020
$4.23B(-40.2%)
-$367.10M(-131.1%)
$4.23B(-35.5%)
Sep 2020
-
$1.18B(-39.4%)
$6.56B(-7.3%)
Jun 2020
-
$1.95B(+32.8%)
$7.07B(-0.2%)
Mar 2020
-
$1.47B(-25.1%)
$7.09B(+0.1%)
Dec 2019
$7.08B(+14.4%)
$1.96B(+15.7%)
$7.08B(+0.9%)
Sep 2019
-
$1.69B(-13.7%)
$7.01B(-0.6%)
Jun 2019
-
$1.96B(+34.6%)
$7.05B(+14.0%)
Mar 2019
-
$1.46B(-23.0%)
$6.19B(+0.0%)
Dec 2018
$6.19B(+36.0%)
$1.90B(+9.2%)
$6.19B(+6.5%)
Sep 2018
-
$1.74B(+57.9%)
$5.81B(+1.9%)
Jun 2018
-
$1.10B(-24.6%)
$5.70B(-1.2%)
Mar 2018
-
$1.46B(-4.0%)
$5.77B(+26.8%)
Dec 2017
$4.55B(-0.8%)
$1.52B(-6.8%)
$4.55B(-1.4%)
Sep 2017
-
$1.63B(+39.3%)
$4.61B(+16.0%)
Jun 2017
-
$1.17B(+397.1%)
$3.98B(+4.5%)
Mar 2017
-
$235.20M(-85.1%)
$3.81B(-17.0%)
Dec 2016
$4.59B(+17.0%)
$1.58B(+59.6%)
$4.59B(+8.0%)
Sep 2016
-
$991.30M(-0.7%)
$4.25B(+2.3%)
Jun 2016
-
$998.20M(-1.7%)
$4.15B(-1.2%)
Mar 2016
-
$1.02B(-18.3%)
$4.20B(+7.2%)
Dec 2015
$3.92B(+33.2%)
$1.24B(+38.9%)
$3.92B(+8.6%)
Sep 2015
-
$895.40M(-14.5%)
$3.61B(-0.5%)
Jun 2015
-
$1.05B(+42.9%)
$3.63B(+1.6%)
Mar 2015
-
$733.00M(-21.4%)
$3.57B(+21.4%)
Dec 2014
$2.94B(+25.5%)
$932.85M(+2.1%)
$2.94B(+2.2%)
Sep 2014
-
$914.03M(-7.7%)
$2.88B(+9.2%)
Jun 2014
-
$990.59M(+846.8%)
$2.64B(+16.1%)
Mar 2014
-
$104.63M(-88.0%)
$2.27B(-3.2%)
Dec 2013
$2.35B(+24.7%)
$869.03M(+29.3%)
$2.35B(+18.2%)
Sep 2013
-
$671.92M(+7.5%)
$1.98B(+7.0%)
Jun 2013
-
$625.21M(+249.4%)
$1.85B(-0.6%)
Mar 2013
-
$178.94M(-64.8%)
$1.86B(-0.8%)
Dec 2012
$1.88B(+8.8%)
$507.91M(-6.3%)
$1.88B(+1.8%)
Sep 2012
-
$541.78M(-14.8%)
$1.85B(-1.5%)
Jun 2012
-
$635.58M(+226.6%)
$1.87B(+12.3%)
Mar 2012
-
$194.63M(-58.9%)
$1.67B(-3.4%)
Dec 2011
$1.73B(+6.3%)
$473.97M(-16.9%)
$1.73B(+2.5%)
Sep 2011
-
$570.52M(+32.8%)
$1.68B(+9.2%)
Jun 2011
-
$429.67M(+69.4%)
$1.54B(+0.1%)
Mar 2011
-
$253.58M(-41.2%)
$1.54B(-5.1%)
Dec 2010
$1.62B(+51.1%)
$431.06M(+0.7%)
$1.62B(+10.3%)
Sep 2010
-
$428.24M(-0.1%)
$1.47B(+12.4%)
Jun 2010
-
$428.48M(+27.2%)
$1.31B(+18.0%)
Mar 2010
-
$336.89M(+20.6%)
$1.11B(+3.4%)
Dec 2009
$1.07B(-31.2%)
$279.34M(+4.9%)
$1.07B(-10.6%)
Sep 2009
-
$266.26M(+16.5%)
$1.20B(-17.0%)
Jun 2009
-
$228.55M(-24.0%)
$1.45B(-3.2%)
Mar 2009
-
$300.75M(-26.2%)
$1.50B(-4.2%)
Dec 2008
$1.56B(+53.1%)
$407.25M(-20.5%)
$1.56B(+4.1%)
Sep 2008
-
$512.19M(+85.6%)
$1.50B(+25.2%)
Jun 2008
-
$276.02M(-24.8%)
$1.20B(+6.6%)
Mar 2008
-
$366.99M(+6.1%)
$1.13B(+10.3%)
Dec 2007
$1.02B
$345.86M(+64.4%)
$1.02B(+11.4%)
Sep 2007
-
$210.43M(+4.2%)
$916.58M(-5.1%)
DateAnnualQuarterlyTTM
Jun 2007
-
$202.02M(-23.0%)
$965.99M(+2.0%)
Mar 2007
-
$262.33M(+8.5%)
$947.34M(+12.6%)
Dec 2006
$841.27M(-5.4%)
$241.81M(-6.9%)
$841.27M(-3.8%)
Sep 2006
-
$259.84M(+41.7%)
$874.20M(+11.0%)
Jun 2006
-
$183.37M(+17.4%)
$787.55M(-5.4%)
Mar 2006
-
$156.25M(-43.1%)
$832.87M(-6.4%)
Dec 2005
$889.50M(+22.2%)
$274.74M(+58.6%)
$889.50M(+11.8%)
Sep 2005
-
$173.19M(-24.3%)
$795.68M(+0.1%)
Jun 2005
-
$228.69M(+7.4%)
$795.05M(+8.1%)
Mar 2005
-
$212.89M(+17.7%)
$735.34M(+1.0%)
Dec 2004
$727.99M(+328.3%)
$180.91M(+4.8%)
$727.99M(+39.5%)
Sep 2004
-
$172.56M(+2.1%)
$521.78M(+21.0%)
Jun 2004
-
$168.98M(-17.8%)
$431.18M(+44.0%)
Mar 2004
-
$205.54M(-912.7%)
$299.46M(+76.2%)
Dec 2003
$169.97M(-5.2%)
-$25.29M(-130.9%)
$169.97M(-17.8%)
Sep 2003
-
$81.96M(+120.0%)
$206.88M(+8.0%)
Jun 2003
-
$37.25M(-51.0%)
$191.62M(-1.2%)
Mar 2003
-
$76.05M(+554.3%)
$193.94M(+8.2%)
Dec 2002
$179.22M(-43.4%)
$11.62M(-82.6%)
$179.22M(-20.4%)
Sep 2002
-
$66.70M(+68.6%)
$225.10M(-8.3%)
Jun 2002
-
$39.57M(-35.5%)
$245.49M(-15.0%)
Mar 2002
-
$61.33M(+6.7%)
$288.78M(-8.8%)
Dec 2001
$316.81M(-13.5%)
$57.50M(-34.0%)
$316.81M(-27.1%)
Sep 2001
-
$87.08M(+5.1%)
$434.58M(+2.4%)
Jun 2001
-
$82.86M(-7.3%)
$424.48M(-3.1%)
Mar 2001
-
$89.35M(-49.0%)
$438.01M(+19.5%)
Dec 2000
$366.39M(+0.8%)
$175.28M(+127.7%)
$366.39M(-6.5%)
Sep 2000
-
$76.98M(-20.1%)
$391.89M(+1.4%)
Jun 2000
-
$96.40M(+443.8%)
$386.31M(+9.9%)
Mar 2000
-
$17.73M(-91.2%)
$351.51M(-3.3%)
Dec 1999
$363.58M(+116.6%)
$200.78M(+181.2%)
$363.58M(+77.5%)
Sep 1999
-
$71.40M(+15.9%)
$204.84M(+7.4%)
Jun 1999
-
$61.60M(+106.7%)
$190.75M(+22.8%)
Mar 1999
-
$29.80M(-29.1%)
$155.34M(-7.4%)
Dec 1998
$167.84M(+71.9%)
$42.05M(-26.6%)
$167.84M(+25.2%)
Sep 1998
-
$57.30M(+118.7%)
$134.03M(+5.6%)
Jun 1998
-
$26.20M(-38.1%)
$126.93M(-5.4%)
Mar 1998
-
$42.30M(+413.8%)
$134.13M(+37.4%)
Dec 1997
$97.63M(+109.8%)
$8.23M(-83.6%)
$97.63M(-31.0%)
Sep 1997
-
$50.20M(+50.3%)
$141.54M(+39.1%)
Jun 1997
-
$33.40M(+475.9%)
$101.74M(+67.0%)
Mar 1997
-
$5.80M(-88.9%)
$60.94M(+30.9%)
Dec 1996
$46.54M(+392.5%)
$52.14M(+401.3%)
$46.54M(+840.4%)
Sep 1996
-
$10.40M(-240.5%)
$4.95M(-225.3%)
Jun 1996
-
-$7.40M(-14.0%)
-$3.95M(-8163.3%)
Mar 1996
-
-$8.60M(-181.5%)
$49.00K(-99.5%)
Dec 1995
$9.45M(-72.9%)
$10.55M(+603.3%)
$9.45M(-224.1%)
Sep 1995
-
$1.50M(-144.1%)
-$7.61M(-2072.5%)
Jun 1995
-
-$3.40M(-525.0%)
$386.00K(-80.6%)
Mar 1995
-
$800.00K(-112.3%)
$1.99M(-94.3%)
Dec 1994
$34.89M(-26.7%)
-$6.51M(-168.6%)
$34.89M(-29.7%)
Sep 1994
-
$9.50M(-627.8%)
$49.60M(+1.6%)
Jun 1994
-
-$1.80M(-105.3%)
$48.80M(-24.5%)
Mar 1994
-
$33.70M(+311.0%)
$64.60M(+35.7%)
Dec 1993
$47.60M(+10.4%)
$8.20M(-5.7%)
$47.60M(-29.9%)
Sep 1993
-
$8.70M(-37.9%)
$67.90M(-3.8%)
Jun 1993
-
$14.00M(-16.2%)
$70.60M(+28.4%)
Mar 1993
-
$16.70M(-41.4%)
$55.00M(+27.6%)
Dec 1992
$43.10M(+630.5%)
$28.50M(+150.0%)
$43.10M(+136.8%)
Sep 1992
-
$11.40M(-812.5%)
$18.20M(+203.3%)
Jun 1992
-
-$1.60M(-133.3%)
$6.00M(-25.0%)
Mar 1992
-
$4.80M(+33.3%)
$8.00M(+35.6%)
Dec 1991
$5.90M(-44.9%)
$3.60M(-550.0%)
$5.90M(-1.7%)
Sep 1991
-
-$800.00K(-300.0%)
$6.00M(-36.2%)
Jun 1991
-
$400.00K(-85.2%)
$9.40M(-37.7%)
Mar 1991
-
$2.70M(-27.0%)
$15.10M(+41.1%)
Dec 1990
$10.70M(-242.7%)
$3.70M(+42.3%)
$10.70M(+52.9%)
Sep 1990
-
$2.60M(-57.4%)
$7.00M(+59.1%)
Jun 1990
-
$6.10M(-458.8%)
$4.40M(-358.8%)
Mar 1990
-
-$1.70M
-$1.70M
Dec 1989
-$7.50M
-
-

FAQ

  • What is Biogen annual cash flow from operations?
  • What is the all time high annual CFO for Biogen?
  • What is Biogen annual CFO year-on-year change?
  • What is Biogen quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Biogen?
  • What is Biogen quarterly CFO year-on-year change?
  • What is Biogen TTM cash flow from operations?
  • What is the all time high TTM CFO for Biogen?
  • What is Biogen TTM CFO year-on-year change?

What is Biogen annual cash flow from operations?

The current annual CFO of BIIB is $2.88B

What is the all time high annual CFO for Biogen?

Biogen all-time high annual cash flow from operations is $7.08B

What is Biogen annual CFO year-on-year change?

Over the past year, BIIB annual cash flow from operations has changed by +$1.33B (+85.85%)

What is Biogen quarterly cash flow from operations?

The current quarterly CFO of BIIB is $259.30M

What is the all time high quarterly CFO for Biogen?

Biogen all-time high quarterly cash flow from operations is $1.96B

What is Biogen quarterly CFO year-on-year change?

Over the past year, BIIB quarterly cash flow from operations has changed by -$293.90M (-53.13%)

What is Biogen TTM cash flow from operations?

The current TTM CFO of BIIB is $2.58B

What is the all time high TTM CFO for Biogen?

Biogen all-time high TTM cash flow from operations is $7.09B

What is Biogen TTM CFO year-on-year change?

Over the past year, BIIB TTM cash flow from operations has changed by +$936.50M (+56.93%)
On this page